Patent details
EP2078032 Title: COMPOSITIONS AND METHODS FOR SUPPRESSING ENDOMETRIAL PROLIFERATION
Basic Information
- Publication number:
- EP2078032
- PCT Application Number:
- US2007082432
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078712320
- PCT Publication Number:
- WO2008067086
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOSITIONS AND METHODS FOR SUPPRESSING ENDOMETRIAL PROLIFERATION
- French Title of Invention:
- COMPOSITIONS ET PROCÉDÉS POUR SUPPRIMER LA PROLIFÉRATION DE L'ENDOMÈTRE
- German Title of Invention:
- ZUSAMMENSETZUNGEN UND VERFAHREN ZUM UNTERDRÜCKEN DER ENDOMETRIALEN PROLIFERATION
- SPC Number:
Dates
- Filing date:
- 24/10/2007
- Grant date:
- 02/08/2017
- EP Publication Date:
- 15/07/2009
- PCT Publication Date:
- 05/06/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/08/2017
- EP B1 Publication Date:
- 02/08/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/10/2021
- Expiration date:
- 24/10/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/12/2019
- Name:
- Allergan Pharmaceuticals International Limited
- Address:
- Clonshaugh Business & Technology Park, Coolock, D17 E400, Dublin, Ireland (IE)
History of Owners
- From:
- 02/08/2017
- To:
- 16/12/2019
- Name:
- Repros Therapeutics Inc.
- Address:
- 2408 Timberloch Place, B-7, The Woodlands, TX 77380, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 02/10/2017
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
- Name:
- PODOLSKI, Joseph, S.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 862632 P
- Priority Date:
- 24/10/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 885348 P
- Priority Date:
- 17/01/2007
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/56; A61K 31/567; A61K 31/57; A61K 31/573; A61K 45/06; A61P 5/34; A61P 5/36;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2020/01
- Publication date:
- 13/01/2020
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
1
- Issue number:
- 201731
- Publication date:
- 02/08/2017
- Description:
- Grant (B1)
2
- Issue number:
- 201736
- Publication date:
- 06/09/2017
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20190000465B
- Date Registered:
- 16/12/2019
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- MARKS & CLERK LLP
- Journal Edition Number:
- Text:
- cession
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Allergan Pharmaceuticals International Limited
- Address:
- Clonshaugh Business & Technology Park, Coolock, D17 E400, Dublin, Ireland (IE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 27/10/2020
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- Computer Packages INC
| Filing date | Document type | Number of pages |
|---|---|---|
| 17/12/2019 | Outgoing Correspondence | 1 |
| 05/10/2017 | Outgoing Correspondence | 1 |
| 02/10/2017 | Power Of Attorney | 2 |
| 17/12/2019 | Outgoing Correspondence | 1 |
| 16/12/2019 | Request For Change | 9 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |